Literature DB >> 11217799

A potent seryl tRNA synthetase inhibitor SB-217452 isolated from a Streptomyces species.

A L Stefanska1, M Fulston, C S Houge-Frydrych, J J Jones, S R Warr.   

Abstract

A potent inhibitor of seryl tRNA synthetase, designated SB-217452 has been isolated from Streptomyces sp. ATCC 700974. The fermentation, isolation, structure elucidation and some properties are described. SB-217452 showed inhibitory activity against both Staphylococcus aureus and rat seryl tRNA synthetases, with similar IC50 values of approximately 8 nM. The inhibitor is the serine linked nucleoside moiety of the antibiotic albomycin delta2. In contrast to albomycin delta2, SB-217452 showed only very weak antibacterial activity against a limited range of microorganisms. The compound has not been previously reported as a naturally occurring metabolite. In addition to SB-217452, albomycin delta2 Fe3+ complex and the novel Al3+ complex were isolated from the fermentation. These complexes had no seryl tRNA synthetase inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11217799     DOI: 10.7164/antibiotics.53.1346

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  27 in total

1.  A biosynthetic pathway for BE-7585A, a 2-thiosugar-containing angucycline-type natural product.

Authors:  Eita Sasaki; Yasushi Ogasawara; Hung-Wen Liu
Journal:  J Am Chem Soc       Date:  2010-06-02       Impact factor: 15.419

Review 2.  FhuA (TonA), the career of a protein.

Authors:  Volkmar Braun
Journal:  J Bacteriol       Date:  2009-03-27       Impact factor: 3.490

Review 3.  Siderophore-based iron acquisition and pathogen control.

Authors:  Marcus Miethke; Mohamed A Marahiel
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

4.  Genetic validation of aminoacyl-tRNA synthetases as drug targets in Trypanosoma brucei.

Authors:  Savitha Kalidas; Igor Cestari; Severine Monnerat; Qiong Li; Sandesh Regmi; Nicholas Hasle; Mehdi Labaied; Marilyn Parsons; Kenneth Stuart; Margaret A Phillips
Journal:  Eukaryot Cell       Date:  2014-02-21

5.  Biosynthetic Origin of the Atypical Stereochemistry in the Thioheptose Core of Albomycin Nucleoside Antibiotics.

Authors:  Richiro Ushimaru; Hung-Wen Liu
Journal:  J Am Chem Soc       Date:  2019-01-30       Impact factor: 15.419

Review 6.  Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics.

Authors:  Christopher S Francklyn; Patrick Mullen
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

7.  A Branch Point of Streptomyces Sulfur Amino Acid Metabolism Controls the Production of Albomycin.

Authors:  Aditya Kulkarni; Yu Zeng; Wei Zhou; Steven Van Lanen; Weiwen Zhang; Shawn Chen
Journal:  Appl Environ Microbiol       Date:  2015-10-30       Impact factor: 4.792

8.  Structure and function of a serine carboxypeptidase adapted for degradation of the protein synthesis antibiotic microcin C7.

Authors:  Vinayak Agarwal; Anton Tikhonov; Anastasia Metlitskaya; Konstantin Severinov; Satish K Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-02       Impact factor: 11.205

Review 9.  Beyond iron: non-classical biological functions of bacterial siderophores.

Authors:  Timothy C Johnstone; Elizabeth M Nolan
Journal:  Dalton Trans       Date:  2015-04-14       Impact factor: 4.390

10.  Sideromycins: tools and antibiotics.

Authors:  Volkmar Braun; Avijit Pramanik; Thomas Gwinner; Martin Köberle; Erwin Bohn
Journal:  Biometals       Date:  2009-01-07       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.